toyocamycin has been researched along with nsc 105827 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Drach, JC; Kim, H; Lee, JS; Renau, TE; Townsend, LB; Wotring, LL; Young, CG | 1 |
Drach, JC; Renau, TE; Townsend, LB; Wotring, LL | 1 |
Breitenbach, JM; Drach, JC; Kennedy, C; Ptak, RG; Renau, TE; Townsend, LB | 1 |
3 other study(ies) available for toyocamycin and nsc 105827
Article | Year |
---|---|
Relationship between cytotoxicity and conversion of thiosangivamycin analogs to toyocamycin analogs in cell culture medium.
Topics: Antibiotics, Antineoplastic; Cell Division; Culture Media; Humans; Structure-Activity Relationship; Thionucleosides; Toyocamycin; Tumor Cells, Cultured | 1994 |
Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
Topics: Antiviral Agents; Cell Survival; Cells, Cultured; Cytomegalovirus; Fibroblasts; Herpesvirus 1, Human; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Microbial Sensitivity Tests; Molecular Structure; Pyrimidine Nucleosides; Pyrimidines; Skin; Structure-Activity Relationship; Thionucleosides; Toyocamycin; Viral Plaque Assay | 1996 |
Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: the effect of certain 4- and 4,6-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidines.
Topics: Antiviral Agents; Cytomegalovirus; Herpesvirus 1, Human; Humans; Pyrimidine Nucleosides; Pyrimidines; Structure-Activity Relationship; Thionucleosides; Toyocamycin | 1996 |